Alnylam Pharmaceuticals
ALNY
#448
Rank
C$71.96 B
Marketcap
C$544.74
Share price
-2.67%
Change (1 day)
56.57%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company